HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NPA Alleges US FDA Bends Time As Well As Rules To Stop NAC’s Use As Dietary Ingredient

Executive Summary

Trade group offers timeline for shift in FDA thinking about the amino acid commonly used in supplements in complaint seeking to block agency from preventing sales of NAC-containing supplements. Complaint also attests that, unlike its current stance, FDA in 1993 acknowledged NAC is lawful for use as a dietary ingredient.

You may also be interested in...



US FDA Misses Point On NAC In Supplements, Avoids Answering Questions, CRN Argues

Council for Responsible Nutrition also argues that not only is agency taking unprecedented path to summarily deem NAC disqualified for use as a dietary ingredient, but also could use same path for other ingredients commonly used in supplements.

Window Of Opportunity Opened Narrowly For Continued Use Of NAC As Dietary Ingredient In US

FDA will “determine if rulemaking to make NAC lawful as a dietary supplement is appropriate.” Agency issued tentative responses to Council for Responsible Nutrition and Natural Products Association’s petitions asking for halt to warnings and other enforcement against firms marketing supplements containing NAC.

AHPA Offers Hard Copy Supporting NAC's Use In Dietary Supplements Pre-DSHEA

American Herbal Products Association submits comments to on CRN and NPA petitions encouraging FDA to grant an industry request to issue a regulation finding NAC is a lawful dietary ingredient.

Related Content

Topics

UsernamePublicRestriction

Register

RS152015

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel